Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
NCT Number: NCT04656470
Neuroimaging data will be collected for patients that are given low doses of dexmedetomidine in order to understand its analgesic effects.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Phase 2 / Phase 3
Boston, Massachusetts, 02114, United States
In this trial, participants will be given dexmedetomidine using a single-arm study design. fMRI will be conducted during this time. Cognitive assessments and pain monitoring will be administered at various points before and after dexmedetomidine is administered.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be delivered dexmedetomidine anesthesia to gain greater understanding of its analgesic effects.
Other names: Precedex
Time frame: During imaging scan
Transient waves of CSF inflow
Massachusetts General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06282666
Acute Pain, Agnosia
Lublin, Poland
View Trial DetailsNCT06762288
Agnosia, Analgesia
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05953363
Agnosia, Analgesia
Salzburg, Austria
View Trial DetailsNCT06630858
Acute Pain, Agnosia
Samsun, Turkey (Türkiye)
View Trial Details